ATE269059T1 - Ein profen enthaltende pharmazeutische mischung - Google Patents

Ein profen enthaltende pharmazeutische mischung

Info

Publication number
ATE269059T1
ATE269059T1 AT99967936T AT99967936T ATE269059T1 AT E269059 T1 ATE269059 T1 AT E269059T1 AT 99967936 T AT99967936 T AT 99967936T AT 99967936 T AT99967936 T AT 99967936T AT E269059 T1 ATE269059 T1 AT E269059T1
Authority
AT
Austria
Prior art keywords
profene
mixture containing
pharmaceutical mixture
profen
pharmaceutical
Prior art date
Application number
AT99967936T
Other languages
English (en)
Inventor
Heinz Einig
Harald Hach
Richard C Thompson
Raymond Eason
Bernd W Mueller
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of ATE269059T1 publication Critical patent/ATE269059T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99967936T 1998-12-18 1999-12-14 Ein profen enthaltende pharmazeutische mischung ATE269059T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11295498P 1998-12-18 1998-12-18
PCT/EP1999/009904 WO2000037054A1 (en) 1998-12-18 1999-12-14 A pharmaceutical mixture comprising a profen

Publications (1)

Publication Number Publication Date
ATE269059T1 true ATE269059T1 (de) 2004-07-15

Family

ID=22346769

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967936T ATE269059T1 (de) 1998-12-18 1999-12-14 Ein profen enthaltende pharmazeutische mischung

Country Status (19)

Country Link
EP (1) EP1140032B1 (de)
JP (1) JP2002532538A (de)
KR (1) KR100700472B1 (de)
CN (1) CN1203845C (de)
AT (1) ATE269059T1 (de)
AU (1) AU2431400A (de)
BR (1) BR9916359A (de)
CA (1) CA2355291C (de)
CZ (1) CZ298604B6 (de)
DE (1) DE69918163T2 (de)
ES (1) ES2224743T3 (de)
HU (1) HUP0104606A3 (de)
IL (2) IL143354A0 (de)
MX (1) MXPA01005918A (de)
NO (1) NO20012998L (de)
RU (1) RU2240109C2 (de)
TW (1) TW575434B (de)
WO (1) WO2000037054A1 (de)
ZA (1) ZA200105860B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
JP5248733B2 (ja) * 2003-11-28 2013-07-31 エスエス製薬株式会社 揮散防止型固形製剤およびその製造方法
JP2010189443A (ja) * 2010-06-07 2010-09-02 Ss Pharmaceut Co Ltd 揮散防止型固形製剤およびその製造方法
MX2011007675A (es) * 2011-07-19 2012-07-11 Cell Therapy And Technology S A De C V Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539198A (en) * 1983-07-07 1985-09-03 Rowell Laboratories, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
ATE92752T1 (de) * 1987-07-08 1993-08-15 American Home Prod Spruehgetrocknete ibuprofen-zusammensetzungen.
GB9119052D0 (en) * 1991-09-06 1991-10-23 Boots Co Plc Pharmaceutical compositions
WO1998058640A1 (en) * 1997-06-23 1998-12-30 Mcneil-Ppc Ibuprofen and diphenhydramine analgesics
AU4797999A (en) * 1998-07-22 2000-02-14 Yamanouchi Pharmaceutical Co., Ltd. Solid preparation containing sparingly soluble nsaids

Also Published As

Publication number Publication date
AU2431400A (en) 2000-07-12
KR100700472B1 (ko) 2007-03-28
CN1330537A (zh) 2002-01-09
HUP0104606A3 (en) 2003-01-28
CA2355291C (en) 2009-05-19
EP1140032A1 (de) 2001-10-10
NO20012998L (no) 2001-06-18
ES2224743T3 (es) 2005-03-01
JP2002532538A (ja) 2002-10-02
CN1203845C (zh) 2005-06-01
HUP0104606A2 (hu) 2002-05-29
CZ20012228A3 (cs) 2002-07-17
CA2355291A1 (en) 2000-06-29
CZ298604B6 (cs) 2007-11-21
BR9916359A (pt) 2001-09-11
IL143354A (en) 2006-10-31
KR20010093186A (ko) 2001-10-27
NO20012998D0 (no) 2001-06-15
IL143354A0 (en) 2002-04-21
TW575434B (en) 2004-02-11
WO2000037054A1 (en) 2000-06-29
DE69918163D1 (de) 2004-07-22
ZA200105860B (en) 2002-07-17
DE69918163T2 (de) 2004-10-28
MXPA01005918A (es) 2005-07-01
RU2240109C2 (ru) 2004-11-20
EP1140032B1 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
ES2118686T3 (es) Extracto estable de hypericum perforatum l., proceso para su preparacion y composiciones farmaceuticas.
ES2142819T3 (es) Composiciones farmaceuticas estabilizadas que comprenden un compuesto inhibidor de hmg-coa reductasa.
RS50035B (sr) Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje
ES2120516T3 (es) Preparacion de composiciones farmaceuticas que contienen una calcitonina.
NO971568L (no) Analoger av keratinocyttvekstfaktor
CO5180587A1 (es) Composicion farmaceutica de orlistat que contiene tensoactivos y dispersantes
BR9612555A (pt) Composições de detergente que contêm precursores de fragância e os precursores de fragância dessas composições
AU5652796A (en) Solid compositions containing polyethyleneoxide and a non-am orphous active principle
ATE269059T1 (de) Ein profen enthaltende pharmazeutische mischung
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
ES2171722T3 (es) Nuevos derivados de la 5-o-desosaminil-6-o-metil-eritronolida a, su procedimiento de preparacion y su aplicacion a la preparacion de productos biologicamente activos.
EA199800993A1 (ru) Композиции, содержащие фосфатидные кислоты
AR022868A2 (es) Dihidrato de mupirocina calcica
NO982229D0 (no) Svovelholdige di-tert-butylfenol-forbindelser anvendbare som antiinflammatoriske midler
ATE263547T1 (de) Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält
ES2055607T3 (es) Composiciones farmaceuticas estables que contienen un factor de crecimiento de fibroblastos.
AU4371396A (en) Detergent composition containing combination of nonionic polysaccharide ether with synthetic oxyalkylene-containing soil release agent
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
ES2149736T1 (es) Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
AR020064A1 (es) Composicion farmaceutica que contiene una combinacion de una proteina osteoinductiva y un factor de dorsalizacion y metodo para su elaboracion.
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
FR2740772B1 (fr) Procede de preparation d'anthraquinones substituees et application a la preparation de rheines
IT1274551B (it) Formulato a base di propionato di cellulosa
TW340787B (en) Ester compounds and harmful organism-controlling agents containing them as active ingredients

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140032

Country of ref document: EP

REN Ceased due to non-payment of the annual fee